Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Compare Target Date versus Index options in 401(k) plans, highlighting cost, diversification, and adaptability. Learn which fund type best fits your retirement timeline.
25,660 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
A quiet, data-driven move by Endeavour Capital Advisors boosted its stake in QCR Holdings in Q1 2026. Learn what this...
IDVO’s $445 million income engine is under renewed pressure as growth at Taiwan Semiconductor slows, raising question...
A major fund recently shed about $20 million worth of Graphic Packaging shares, prompting questions about the company...
When a large manager trims a position, questions follow. This article breaks down Hilton Capital’s $25 million GPIX s...
Accenture stock has faced a setback as AI and market shifts weigh on the stock. This guide explains the drivers behin...
Starting with $1,000 in artificial intelligence (ai) stocks can feel daunting. This guide breaks down a practical pla...
The S&P 500 is doing something unseen more in modern markets, hinting at far-reaching implications for portfolios. Hi...
As markets shift away from giant tech names, a Vanguard built market approach centers on value, dividends, and steady...
Tech stocks led the rebound as tensions eased, lifting the Nasdaq while broad indices followed. Here’s what happened,...
Oil-driven weakness pushed the S&P 500 lower in a volatile March session. SPY skidded as energy names led declines, w...
When fear takes the wheel, investors often forget the basics. This guide lays out three practical reminders to stay t...